DineshKhannaMD
Rheumatology • Ann Arbor, MIFrederick GL Huetwell Professor of Medicine, Director, Scleroderma Program, University of Michigan
Dr. Khanna is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E Medical Center Dr
3rd Floor Taubman Center Recp A
Ann Arbor, MI 48105Phone+1 734-647-5900
Summary
- I am board certified in rheumatology and direct the University of Michigan Scleroderma Program.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Rheumatology, 2000 - 2003
Wright State UniversityResidency, Internal Medicine, 1997 - 2000
Delhi University College of Medical SciencesClass of 1996
Certifications & Licensure
MI State Medical License 2011 - 2027
OH State Medical License 1999 - 2008- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FACR) American College of Rheumatology
Clinical Trials
- Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients Start of enrollment: 2005 Feb 01
- Curcumin in Rheumatoid Arthritis Start of enrollment: 2010 Jan 01
- Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH) Start of enrollment: 2011 Jun 24
- Join now to see all
Publications & Presentations
PubMed
- Development and Initial Validation of the Novel Scleroderma Clinical Trials Consortium Activity Index.Laura Ross, Dylan Hansen, Susanna Proudman, Dinesh Khanna, Ariane L Herrick
Arthritis & Rheumatology. 2024-11-01 - 1 citationsBiomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosis.Dinesh Khanna, Frank Kramer, Josef Höfler, Mercedeh Ghadessi, Peter Sandner
Rheumatology. 2024-11-01 - 1 citationsPeer-Led Symptom Management Intervention to Enhance Resilience in People With Systemic Sclerosis: Mediation Analysis From a Randomized Clinical Trial.Yen T Chen, Afton L Hassett, Suiyuan Huang, Dinesh Khanna, Susan L Murphy
Arthritis Care & Research. 2024-09-01
Journal Articles
- ReplyDinesh Khanna, Elana J Bernstein, David J Lederer, Arthritis & Rheumatology
- Ongoing Clinical Trials and Treatment Options for Patients with Systemic Sclerosis–Associated Interstitial Lung DiseaseDonald P Tashkin, Dinesh Khanna, Rheumatology
- Safety and Efficacy of Subcutaneous Tocilizumab in Systemic Sclerosis: Results from the Open-Label Period of a Phase II Randomised Controlled Trial (faSScinate)Dinesh Khanna, Daniel Eric Furst, Emergency Medicine Journal
Press Mentions
Arthritis Drug Shows Promise Against Autoimmune Disease SclerodermaOctober 11th, 2022- How the Western Diet and Gut Bacteria Can Lead to Scarring, Vessel Damage in SclerodermaAugust 23rd, 2022
- Two Steps Forward, One Step Back: Hunting for a Game-Changer in SclerodermaMarch 22nd, 2022
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
